id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0446-0002,FDA,FDA-2013-D-0446,Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers,Other,Guidance,2013-05-09T04:00:00Z,2013,5,2013-05-09T04:00:00Z,,2024-11-12T05:15:16Z,,1,0,09000064812cd344
FDA-2013-D-0446-0001,FDA,FDA-2013-D-0446,Draft Guidance for Industry on Expanded Access to Investigational Drugs for Treatment Use--Questions and Answers; Availability,Notice,Notice of Availability,2013-05-09T04:00:00Z,2013,5,2013-05-09T04:00:00Z,2013-07-09T03:59:59Z,2014-06-19T01:01:23Z,2013-11005,0,0,09000064812cd343